Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
Latest Publications
RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro.
Loh NY. et al, (2020), Nat Commun, 11
δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.
Briant LJB. et al, (2018), J Physiol, 596, 197 - 215
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Mentz RJ. et al, (2017), Am Heart J, 187, 1 - 9
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Howles SA. et al, (2017), JCI Insight, 2
Latest News
Diabetes Trial Unit leads on UK trial sites testing potential COVID-19 preventatives
21 May 2020
The DTU is managing the UK sites for a global study testing if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers.
Removing body clock gene protects mice against pneumonia
7 January 2020
OCDEM researcher wins British Endocrinology Society prize
27 November 2019
Dr Nikolaos Nikolaou won the prize for the Best Metabolism and Obesity Oral Communication Prize at the 2019 British Endocrinology Society conference.
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.